ArticleOrthopedic reviews2016
Total Elbow Arthroplasty in the United States: Evaluation of Cost, Patient Demographics, and Complication Rates.
Article in Orthopedic reviews, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed, 55 citations in OpenAlex.
- Comparison of inpatient charges and costs between revision and primary total elbow arthroplasty in the New York state.JSES reviews, reports, and techniques · 2026Article
- Current outcomes of triceps-sparing elbow arthroplasties: a systematic review.JSES reviews, reports, and techniques · 2026Review
- Periprosthetic Humeral Shaft Fracture about Total Elbow Arthroplasties Managed with Medial and Lateral Femoral Strut Allografts and Implant Retention: A Case Report.Journal of orthopaedic case reports · 2025Article
- Analyzing Declining Trends, Patient Demographics, and Complications in Total Elbow Arthroplasty: Nationwide Retrospective Data Analysis.Journal of clinical medicine · 2025Article
- Description of a new surgical approach for elbow arthroplasty: Selective Triceps-On Medial Paraolecranon (STOMP) approach.JSES international · 2025Article
- Is popularity of total elbow arthroplasty in the United States decreasing? An analysis of trends, demographics, and indications.JSES reviews, reports, and techniques · 2024Article
- Sex Disparities Affecting Postoperative Outcomes After Total Elbow Arthroplasty.Journal of hand surgery global online · 2024Article
- New materials and complications of prostheses in humans: situation in Spain.Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia · 2024Review
- Restoring Functionality: Humeroradial Total Elbow Revision for Salvaging Total Elbow Arthroplasty Failure and Ulnar Bone Loss.Journal of shoulder and elbow arthroplasty · 2024Article
- Inpatient or outpatient total elbow arthroplasty: a comparison of patient populations and 30-day surgical outcomes from the American College of Surgeons National Surgical Quality Improvement Program.Clinics in shoulder and elbow · 2023Article
- The 5-Item Modified Frailty Index for Risk Stratification of Patients Undergoing Total Elbow Arthroplasty.Hand (New York, N.Y.) · 2023Article
- Anemia Severity and the Risks of Postoperative Complications and Extended Length of Stay Following Primary Total Elbow Arthroplasty.Hand (New York, N.Y.) · 2023Article
- Comparison of 90-day complication rates and readmissions of primary total elbow arthroplasty in elective and traumatic cases: a single center experience.European journal of orthopaedic surgery & traumatology : orthopedie traumatologie · 2023Article
- Utilization, Complications, and Costs of Inpatient versus Outpatient Total Elbow Arthroplasty.Hand (New York, N.Y.) · 2023Article
- Identification of Independent Predictors of Increased 90-Day Complication and Revision Rates Following Total Elbow Arthroplasty.Journal of shoulder and elbow arthroplasty · 2023Article
- Is venous thromboembolism prophylaxis beneficial in upper limb major joint replacement surgery? A systematic review.Shoulder & elbow · 2021Review
- The transition of total elbow arthroplasty into the outpatient theater.JSES international · 2020Article
- Total Elbow Arthroplasty: Clinical Outcomes, Complications, and Revision Surgery.Clinics in orthopedic surgery · 2019Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Total elbow arthroplasty (TEA) is utilized in the treatment of rheumatoid and post-traumatic elbow arthritis. TEA is a relatively low volume surgery in comparison to other types of arthroplasty and therefore little is known about current surgical utilization, patient demographics and complication rates in the United States. The purpose of our study is to evaluate the current practice trends and associated in-patient complications of TEA at academic centers in the United States. We queried the University Health Systems Consortium administrative database from 2007 to 2011 for patients who underwent an elective TEA. A descriptive analysis of demographics was performed which included patient age, sex, race, and insurance status. We also evaluated the following patient clinical benchmarks: hospital length of stay (LOS), hospital direct cost, in-hospital mortality, complications, and 30-day readmission rates. Our cohort consisted of 3146 adult patients (36.5% male and 63.5% female) with an average age of 58 years who underwent a total elbow arthroplasty (159 academic medical centers) in the United States. The racial demographics included 2334 (74%) Caucasian, 285 (9%) black, 236 (7.5%) Hispanic, 16 (0.5%) Asian, and 283 (9%) other patients. The mean LOS was 4.2±5 days and the mean total direct cost for the hospital was 16,300±4000 US Dollars per case. The overall inpatient complication rate was 3.1% and included mortality <1%, DVT (0.8%), re-operation (0.5%), and infection (0.4%). The 30-day readmission rate was 4.4%. TEA is a relatively uncommon surgery in comparison to other forms of arthroplasty but is associated with low in-patient and 30-day perioperative complication rate. Additionally, the 30-day readmission rate and overall hospital costs are comparable to the traditional total hip and knee arthroplasty surgeries.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.